Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-21

Clinical Trial Update: Development of Visual Function Evaluation Method (2)

View source ↗

Summary

Astellas-sponsored clinical trial update describes the development of a visual function evaluation method for Retinitis Pigmentosa, with the study status shown …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Retinitis Pigmentosa | Status: COMPLETED